Physician profile
Gregory R Boco
NPI 1386999548
$7,772.74
in general payments reported to CMS, 2019-2025
25 companies · $1,271 in 2025
The $1,271 reported for 2025 was more than what 75% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,866 · 2020: $302 · 2021: $766 · 2022: $2,012 · 2023: $633 · 2024: $923 · 2025: $1,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,142 · Travel and Lodging: $359 · Long Term Medical Supply Or Device Loan: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,141.97 |
| Travel and Lodging | $359.47 |
| Long Term Medical Supply Or Device Loan | $324.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,005.75 | 2022-2025 | |
| Southern Edge Orthopaedics, INC. | $1,409.00 | 2019 | |
| Biotissue Holdings INC. | $868.15 | 2021-2025 | |
| Smith+Nephew, INC. | $770.79 | 2019-2025 | Collagenase Santyl, Oasis, Acticoat 4" X 4" |
| Integra Lifesciences Corporation | $509.37 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Abbott Laboratories | $378.48 | 2023-2025 | Proclaim, Esprit |
| Djo, LLC | $317.93 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $247.48 | 2020-2024 | Xarelto |
| Acera Surgical, INC. | $229.43 | 2022-2024 | Restrata Wound Matrix |
| Paratek Pharmaceuticals, INC. | $165.69 | 2023-2025 | Nuzyra |
| Horizon Therapeutics Plc | $160.42 | 2021-2023 | Krystexxa |
| Amgen INC. | $149.50 | 2025 | Krystexxa |
| Depuy Synthes Sales INC. | $117.63 | 2021-2025 | Motoband |
| Stryker Corporation | $100.68 | 2019-2024 | Vitoss |
| Novo Nordisk INC | $56.39 | 2020-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $52.33 | 2020 | |
| Amarin Pharma, INC. | $44.31 | 2020 | |
| Wright Medical Technology, INC. | $35.58 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $34.09 | 2021 | |
| Angiodynamics, INC. | $30.00 | 2022 | |
| Organogenesis INC. | $22.20 | 2022 | |
| Curonix LLC | $21.95 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $20.43 | 2021 | |
| Glaxosmithkline, LLC. | $13.08 | 2019 | |
| Kerecis Limited | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Boco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.